Dr. Martens (DOCS.L) • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
You don't hold DOCS.L in your mock portfolio yet.
A PE ratio of 24.77 against an EPS of only 0.03 implies the market is paying a relatively high multiple for very thin earnings, suggesting a stretched valuation relative to current profitability. Without evidence of strong revenue or margin expansion, this combination points to weak underlying earnings power and limited cushion if growth disappoints.
The stock has gained 9.7% over the last month and is trading above its 200-day moving average of $71.54, a constructive medium-term technical signal. However, an RSI of 39.20 sits in the lower-neutral range, indicating neither oversold nor overbought conditions and suggesting the recent bounce may be more of a stabilization than a strong uptrend.
Alternative data show a brand with large but largely stagnant or slightly declining digital and hiring footprints. Web traffic is low for a global consumer brand, job openings are down 13.9% month over month, and social media followings are mostly flat to slightly negative, which together suggest muted demand growth and cautious expansion.
Despite a recent price rebound and a position above the 200-day moving average, Dr. Martens’ thin earnings (EPS 0.03) and relatively high PE multiple leave the stock looking vulnerable if growth does not accelerate. Alternative data—soft web traffic, reduced hiring, and flat social metrics—do not currently support a strong growth narrative, tilting the overall outlook bearish.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started